Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX2RXV
|
||||
| Drug Name |
N-tert-Butyl-2-{(3R,5S,7R)-3-[3-(3-fluoro-phenyl)-ureido]-2-oxo-7-phenyl-5-o-tolyl-azepan-1-yl}-acetamide
|
||||
| Synonyms |
CHEMBL327496
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Formula |
C32H37FN4O3
|
||||
| Canonical SMILES |
Cc1ccccc1[C@H]2C[C@@H](NC(=O)Nc3cccc(F)c3)C(=O)N(CC(=O)NC(C)(C)C)[C@H](C2)c4ccccc4
|
||||
| InChI |
InChI=1S/C32H37FN4O3/c1-21-11-8-9-16-26(21)23-17-27(35-31(40)34-25-15-10-14-24(33)19-25)30(39)37(20-29(38)36-32(2,3)4)28(18-23)22-12-6-5-7-13-22/h5-16,19,23,27-28H,17-18,20H2,1-4H3,(H,36,38)(H2,34,35,40)/t23-,27+,28+/m0/s1
|
||||
| InChIKey |
RUXGBVNMEPICAJ-MLKSZZLFSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Gastrin/cholecystokinin type B receptor | Target Info | [1] | ||
| Cholecystokinin receptor type A | Target Info | [1] | |||
| KEGG Pathway | Calcium signaling pathway | ||||
| Neuroactive ligand-receptor interaction | |||||
| Gastric acid secretionhsa04020:Calcium signaling pathway | |||||
| Insulin secretion | |||||
| Pancreatic secretion | |||||
| PANTHER Pathway | CCKR signaling map ST | ||||
| PathWhiz Pathway | Gastric Acid Production | ||||
| Reactome | Peptide ligand-binding receptors | ||||
| G alpha (q) signalling events | |||||
| Gastrin-CREB signalling pathway via PKC and MAPKR-HSA-375276:Peptide ligand-binding receptors | |||||
| WikiPathways | GPCRs, Class A Rhodopsin-like | ||||
| Gastrin-CREB signalling pathway via PKC and MAPK | |||||
| Secretion of Hydrochloric Acid in Parietal Cells | |||||
| Peptide GPCRs | |||||
| GPCR ligand binding | |||||
| GPCR downstream signaling | |||||
| GPCRs, OtherWP455:GPCRs, Class A Rhodopsin-like | |||||
| References | |||||
| REF 1 | URL: https://www.ebi.ac.uk/chembl/ The ChEMBL database in 2017 | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.